Advertisement
ABEO vs IVA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a StrongBuy and IVA is a Hold.
ABEO's Stochastic Oscillator dives oversold zone
The Stochastic Oscillator for ABEO moved into oversold territory on October 23, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ABEO's RSI Oscillator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in 212 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
ABEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ABEO turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 34 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
The 50-day moving average for ABEO moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ABEO entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.965) is normal, around the industry mean (3.035). P/E Ratio (-3.636) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (13.089) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. ABEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IVA's Stochastic Oscillator stays in overbought zone for 1 day
Expect a price pull-back in the near future.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for IVA entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IVA's RSI Oscillator exited the oversold zone, 29 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on IVA as a result. In 72 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for IVA just turned positive on October 20, 2026. Looking at past instances where IVA's MACD turned positive, the stock continued to rise in 29 of 39 cases over the following month. The odds of a continued upward trend are 74%.
Following a +4.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVA advanced for three days, in 175 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
IVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. IVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.854) is normal, around the industry mean (3.035). P/E Ratio (-7.000) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (136.986) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ABEO | IVA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 79 | 62 | |
P/E GROWTH RATING 1..100 | 98 | 23 | |
SEASONALITY SCORE 1..100 | n/a | 43 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABEO's Valuation (30) in the Pharmaceuticals Generic industry is significantly better than the same rating for IVA (99) in the null industry. This means that ABEO’s stock grew significantly faster than IVA’s over the last 12 months.
ABEO's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as IVA (100) in the null industry. This means that ABEO’s stock grew similarly to IVA’s over the last 12 months.
ABEO's SMR Rating (98) in the Pharmaceuticals Generic industry is in the same range as IVA (100) in the null industry. This means that ABEO’s stock grew similarly to IVA’s over the last 12 months.
IVA's Price Growth Rating (62) in the null industry is in the same range as ABEO (79) in the Pharmaceuticals Generic industry. This means that IVA’s stock grew similarly to ABEO’s over the last 12 months.
IVA's P/E Growth Rating (23) in the null industry is significantly better than the same rating for ABEO (98) in the Pharmaceuticals Generic industry. This means that IVA’s stock grew significantly faster than ABEO’s over the last 12 months.
| ABEO | IVA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 83% | 3 days ago 81% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Momentum ODDS (%) | N/A | 3 days ago 74% |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 74% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 80% | 3 days ago 76% |
| Advances ODDS (%) | 21 days ago 83% | 3 days ago 75% |
| Declines ODDS (%) | 3 days ago 84% | 13 days ago 85% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 74% | 3 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABEO’s FA Score shows that 1 FA rating(s) are green while IVA’s FA Score has 1 green FA rating(s).
- ABEO’s FA Score: 1 green, 4 red.
- IVA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABEO’s TA Score shows that 4 TA indicator(s) are bullish while IVA’s TA Score has 5 bullish TA indicator(s).
- ABEO’s TA Score: 4 bullish, 4 bearish.
- IVA’s TA Score: 5 bullish, 3 bearish.
Price Growth
ABEO (@Biotechnology) experienced а -0.68% price change this week, while IVA (@Biotechnology) price change was +26.19% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.
Reported Earning Dates
ABEO is expected to report earnings on Nov 11, 2026.
IVA is expected to report earnings on Nov 23, 2026.
Industries' Descriptions
@Biotechnology (+1.24% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MEMA | 28.71 | 0.72 | +2.56% |
| Man Active Emerging Markets Alternative ETF (MEMA) | |||
| IETC | 105.59 | 0.28 | +0.27% |
| iShares U.S. Tech Independence Focused ETF (IETC) | |||
| GTND | 25.75 | N/A | N/A |
| Goaltender ETF (GTND) | |||
| GRNB | 23.41 | -0.04 | -0.17% |
| VanEck Green Bond ETF (GRNB) | |||
| DBEF | 54.29 | -0.21 | -0.39% |
| Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) | |||
IVA and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVA has been loosely correlated with ABEO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then ABEO could also see price increases.
| Ticker / NAME | Correlation To IVA | 1D Price Change % | ||
|---|---|---|---|---|
| IVA | 100% | +3.06% | ||
| ABEO - IVA | 38% Loosely correlated | -1.57% | ||
| TVGN - IVA | 37% Loosely correlated | -2.54% | ||
| SLDB - IVA | 36% Loosely correlated | -4.36% | ||
| CELC - IVA | 35% Loosely correlated | -0.49% | ||
| IMNM - IVA | 33% Loosely correlated | -1.48% | ||
More | ||||